Erica Barnell, MD ’23, PhD ’23
Erica Barnell, MD ’23, PhD ’23, is leading the next era of cancer detection as co-founder and chief medical and science officer of Geneoscopy. In her story, discover how she and her brother created ColoSense®, the first FDA-approved, noninvasive colorectal cancer screening home test that detects signs of cancer from RNA.
All alumni spotlights
Erica Barnell, MD ’23, PhD ’23
Erica Barnell, MD ’23, PhD ’23, is leading the next era of cancer detection as co-founder and chief medical and science officer of Geneoscopy. In her story, discover how she and her brother created ColoSense®, the first FDA-approved, noninvasive colorectal cancer screening home test that detects signs of cancer from RNA.
Kory Lavine, MD ’08, PhD ’08
As a cardiologist and scientist, Kory Lavine, MD ’08, PhD ’08, is pioneering therapies that move beyond managing symptoms of heart disease to actively curing it. His research is transforming how we understand heart failure by revealing an unexpected player in the process: the immune system.
Ansuman Satpathy, MD ’14, PhD ’14
Ansuman “Ansu” Satpathy, MD ’14, PhD ’14, has built a career at the intersection of scientific discovery, biotech and entrepreneurship. Now, his work is turning the complexities of the immune system into real hope for patients.
Roger Perlmutter, MD ’79, PhD ’79
Roger Perlmutter, MD ’79, PhD ’79, began his path to revolutionizing modern medicine in the labs of WashU Medicine. In this story, read more about his distinguished career in academia and leadership, including how he championed one of the most successful immunotherapies for breast, colorectal and endometrial cancer.